Skip to content
HowShorted

Arcturus Therapeutics Holdings Inc. short interest in 2025

In 2025, Arcturus Therapeutics Holdings Inc.'s disclosed short interest ran from 18.62% of shares outstanding on 15 Jan 2025 to 25.20% on 31 Dec 2025, a change of +6.58 percentage points. The year's high was 32.42% on 14 Nov 2025 and its low 15.47% on 28 Feb 2025, averaging 20.18% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.18 days on 30 Apr 2025. Full history: Arcturus Therapeutics Holdings Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Arcturus Therapeutics Holdings Inc. in 2025

2025 in figures

Start of year
18.62% (15 Jan 2025)
End of year
25.20% (31 Dec 2025)
Change
+6.58 pp
High
32.42% (14 Nov 2025)
Low
15.47% (28 Feb 2025)
Average
20.18%
Highest days to cover
14.18 (30 Apr 2025)
SEC filings marked
8

Every report in 2025

Arcturus Therapeutics Holdings Inc. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 202518.62%11.85
31 Jan 202516.77%11.84
14 Feb 202515.61%9.92
28 Feb 202515.47%9.96
14 Mar 202516.26%9.9410-K filed, results (8-K)
31 Mar 202517.14%13.12
15 Apr 202518.70%9.47
30 Apr 202518.94%14.18
15 May 202519.96%11.8210-Q filed, results (8-K)
30 May 202520.30%12.84
13 Jun 202518.31%10.06
30 Jun 202518.58%9.59
15 Jul 202516.52%10.21
31 Jul 202516.12%11.81
15 Aug 202518.94%5.9510-Q filed, results (8-K)
29 Aug 202519.92%9.60
15 Sep 202521.90%12.72
30 Sep 202518.94%6.34
15 Oct 202519.56%5.11
31 Oct 202525.59%2.32
14 Nov 202532.42%9.14results (8-K), 10-Q filed
28 Nov 202527.49%8.25
15 Dec 202527.12%9.84
31 Dec 202525.20%11.50

See also: Arcturus Therapeutics Holdings Inc.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.